CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
8 research outputs found
Safety of besifloxacin ophthalmic suspension 0.6% as a prophylactic antibiotic following routine cataract surgery: results of a prospective, parallel-group, investigator-masked study
Author
Berdy Gregg J
Brusatti Robert
Gira Joseph
Malhotra Ranjan
Publication venue
Dove Medical Press
Publication date
Field of study
Get PDF
Crossref
PubMed Central
Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study
Author
Berdy Gregg
Carlisle-Wilcox Cindy
+7Â more
Douglass David
Haque Sameena
Lievens Christopher
Lin Hugh
Montaquila Stephen
Simmons Peter
Vehige Joseph
Publication venue
Digital Commons@Becker
Publication date
01/01/2019
Field of study
Get PDF
Digital Commons@Becker
The Effects of Systemic Medication on Ocular Allergic Disease
Author
Gregg J. Berdy
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Ocular Allergic Disorders and Dry Eye Disease: Associations, Diagnostic Dilemmas, and Management ( Note
Author
Bo Hedqvist
Gregg J. Berdy
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Allergic Conjunctivitis: A Survey of New Antihistamines
Author
GREGG J. BERDY
LISA M. SMITH
+3Â more
MARK B. ABELSON
MICHELLE A. GEORGE
RICHARD L. GIOVANONI
Publication venue
'Mary Ann Liebert Inc'
Publication date
Field of study
No full text
Crossref
Pemirolast Potassium 0.1% Ophthalmic Solution is an Effective Treatment for Allergic Conjunctivitis: A Pooled Analysis of Two Prospective, Randomized, Double-masked, Placebo-controlled, Phase III Studies
Author
Abelson M.B
Abelson M.B.
+17Â more
Abelson M.B.
Adrienne L. Graves
Berdy G.J.
Dinowitz M.
Fujimiya H.
Fujimiya H.
Gregg J. Berdy
Lawrence D. Amdahl
Leonardi A
Mark B. Abelson
Mibu H.
Nakagawa Y.
Nakamura Y.
Nakamura Y.
Sakuma Y.
Thomas Mundorf
Titi J.M
Publication venue
'Mary Ann Liebert Inc'
Publication date
Field of study
No full text
Crossref
Ocular allergic disorders: Disease entities and differential diagnoses
Author
A.M. Irani
A.S.F. Ash
+27Â more
D. Granet
D.A. Owen
D.A. Sullivan
D.J. Hanahan
D.W. Lamberts
E.B. Cook
F.C. Foreman
F.H. Chilton
Gregg J. Berdy
H. Sjogren
I. Robertson
J. Baum
J.A. Warner
J.W. Black
L. Bielory
L.B. Schwartz
M.A. Lemp
M.R. Allansmith
P.J. Barnes
R.J. Flowers
R.L. Farris
R.P. Harvey
R.P. Siraganian
S.H. Snyder
S.J. Ono
Susan S. Berdy
T. Ishizaka
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Perception and quality of life associated with the use of olopatadine 0.2% (Patadayâ„¢) in patients with active allergic conjunctivitis
Author
A Richter
AJ Claxton
+28Â more
CT Vogelson
Cullen T. Vogelson
Curtis Waycaster
EF Juniper
EF Juniper
G Ciprandi
Gregg J. Berdy
H Ishii
H Nonaka
Jay M. Rubin
JM Yanni
JM Yanni
Marc Bloomenstein
MB Abelson
MB Abelson
MB Abelson
Michael R. Edwards
MR Allansmith
NA Sharif
NA Sharif
Robert D. Gross
Robert E. Prouty
Stella M. Robertson
Stephen V. Scoper
Steven J. Lichtenstein
T Hawkins
Terri Pasquine
WE Berger
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref